BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 36747161)

  • 1. LncRNA WEE2-AS1 is a diagnostic biomarker that predicts poor prognoses in patients with glioma.
    Zhu X; Chen D; Sun Y; Yang S; Wang W; Liu B; Gao P; Li X; Wu L; Ma S; Lin W; Ma J; Yan D
    BMC Cancer; 2023 Feb; 23(1):120. PubMed ID: 36747161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High LYRM4-AS1 predicts poor prognosis in patients with glioma and correlates with immune infiltration.
    Wang HY; Xie Y; Du H; Luo B; Li Z
    PeerJ; 2023; 11():e16104. PubMed ID: 37810780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Value of Immune-Related lncRNA SBF2-AS1 in Diffuse Lower-Grade Glioma.
    Zhang Q; Liu XJ; Li Y; Ying XW; Chen L
    Technol Cancer Res Treat; 2021; 20():15330338211011966. PubMed ID: 34159865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA WAC-AS1 expression in human tumors correlates with immune infiltration and affects prognosis.
    Wang Y; Gong H; Cao Y
    Hereditas; 2023 May; 160(1):26. PubMed ID: 37248547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PAXIP1-AS1 is associated with immune infiltration and predicts poor prognosis in ovarian cancer.
    Chen B; Lu X; Zhou Q; Chen Q; Zhu S; Li G; Liu H
    PLoS One; 2023; 18(8):e0290031. PubMed ID: 37582104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MCM10 as a novel prognostic biomarker and its relevance to immune infiltration in gliomas.
    Tian QS; Zhang Q; Huang W
    Technol Health Care; 2023; 31(4):1301-1317. PubMed ID: 36872806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CAF-derived exosomal WEE2-AS1 facilitates colorectal cancer progression via promoting degradation of MOB1A to inhibit the Hippo pathway.
    Yang P; Zhang D; Wang T; Ji J; Jin C; Peng C; Tan Y; Zhou J; Wang L; Feng Y; Sun Y
    Cell Death Dis; 2022 Sep; 13(9):796. PubMed ID: 36123327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA MSC-AS1 Is a Diagnostic Biomarker and Predicts Poor Prognosis in Patients With Gastric Cancer by Integrated Bioinformatics Analysis.
    Yang W; Ge F; Lu S; Shan Z; Peng L; Chai J; Liu H; Li B; Zhang Z; Huang J; Hua Y; Zhang Y
    Front Med (Lausanne); 2021; 8():795427. PubMed ID: 34926534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Long Noncoding RNA ZEB1-AS1 Promotes Tumorigenesis and Predicts Poor Prognosis in Glioma.
    Lv QL; Hu L; Chen SH; Sun B; Fu ML; Qin CZ; Qu Q; Wang GH; He CJ; Zhou HH
    Int J Mol Sci; 2016 Aug; 17(9):. PubMed ID: 27589728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of Long Noncoding RNA ZNF667-AS1 as a Potential Biomarker for Diagnosis and Prognosis of Glioma Patients.
    Yuan Q; Gao C; Lai XD; Chen LY; Lai TB
    Dis Markers; 2020; 2020():8895968. PubMed ID: 33282010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic and Prognostic Potentials of Long Noncoding RNA ELF3-AS1 in Glioma Patients.
    Mei JC; Yan G; Mei SQ
    Dis Markers; 2020; 2020():8871746. PubMed ID: 33014189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA FOXP4-AS1 is a prognostic biomarker and associated with immune infiltrates in ovarian serous cystadenocarcinoma.
    Liao C; Wang A; Ma Y; Liu H
    Medicine (Baltimore); 2021 Oct; 100(40):e27473. PubMed ID: 34622876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The N
    Li B; Zhao R; Qiu W; Pan Z; Zhao S; Qi Y; Qiu J; Zhang S; Guo Q; Fan Y; Xu H; Li M; Li G; Xue H
    Theranostics; 2022; 12(14):6363-6379. PubMed ID: 36168628
    [No Abstract]   [Full Text] [Related]  

  • 14. LINC01094 Predicts Poor Prognosis in Patients With Gastric Cancer and is Correlated With EMT and Macrophage Infiltration.
    Ye Y; Ge O; Zang C; Yu L; Eucker J; Chen Y
    Technol Cancer Res Treat; 2022; 21():15330338221080977. PubMed ID: 35254147
    [No Abstract]   [Full Text] [Related]  

  • 15. [Bioinformatics analysis of the association between long non-coding RNA ubiquitin-specific peptidase 30 antisense RNA 1 (lncRNA USP30-AS1) and immune cell infiltration in ovarian serous cystadenocarcinoma].
    Wang H; Huang S; Meng Q; Zhang J; Wei L
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2023 Sep; 39(9):834-840. PubMed ID: 37732580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive analysis of oxidative stress-related lncRNA signatures in glioma reveals the discrepancy of prognostic and immune infiltration.
    Shi Z; Wu Y; Zhuo Q; Zuo Y; Lin J; Shi H; Zhou H; Xu Z
    Sci Rep; 2023 May; 13(1):7731. PubMed ID: 37173373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA ELF3-AS1 is a Prognostic Biomarker and Correlated with Immune Infiltrates in Hepatocellular Carcinoma.
    Chen T; Zhu C; Wang X; Pan Y
    Can J Gastroenterol Hepatol; 2021; 2021():8323487. PubMed ID: 34336727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long Noncoding RNA WEE2-AS1 Plays an Oncogenic Role in Glioblastoma by Functioning as a Molecular Sponge for MicroRNA-520f-3p.
    Lin H; Zuo D; He J; Ji T; Wang J; Jiang T
    Oncol Res; 2021 Mar; 28(6):591-603. PubMed ID: 32838835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel Necroptosis-Related lncRNA Signature for Predicting Prognosis and Immune Response of Glioma.
    Wu Z; Liu M; Fu J; Li J; Qin L; Wu L; Chen H; Yan X; Liu Q; Zheng J
    Biomed Res Int; 2022; 2022():3742447. PubMed ID: 35757472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA WEE2-AS1 promotes proliferation and inhibits apoptosis in triple negative breast cancer cells via regulating miR-32-5p/TOB1 axis.
    Wang R; Huang Z; Qian C; Wang M; Zheng Y; Jiang R; Yu C
    Biochem Biophys Res Commun; 2020 Jun; 526(4):1005-1012. PubMed ID: 32307083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.